Acquiring Company
Biosergen AB
Acquired Company
Flerie AB
SwedenSwedenBiotechnologyHealth CareBiotechnologyFinancial ServicesHealth CareFinanceVenture CapitalAngel InvestmentMedicalDescription
Biosergen has applied for the delisting of its shares from the Nasdaq First North Growth Market. This move is conditional upon the completion of its merger with Flerie, indicating a strategic shift for both companies. The merger is expected to enhance their operational capabilities and product offerings.
Quick answer
Biosergen AB is acquiring Flerie AB, announced September 15, 2026. Biosergen AB is based in Sweden.
- How much did Biosergen AB pay for Flerie AB?
- The deal value was not disclosed.
- What does Biosergen AB do?
- Biosergen AB is a biotechnology company that develops innovative drug candidates for treating serious infections, particularly invasive fungal infections.
- Where are Biosergen AB and Flerie AB based?
- Biosergen AB is based in Sweden. Flerie AB is based in Sweden.
- Who are the decision-makers at Biosergen AB?
- Fundz holds 1 contact at Biosergen AB. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Financial Services and Finance
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- EQT completes acquisition of Coller Capital (August 31, 2026)
- Liontrust to acquire Hawksmoor for £6m, $7.8M (September 30, 2026)
- Webster Equity Partners to acquire Lifecore Biomedical (September 29, 2026)
- Miri Capital acquires STIC Investments stake (August 6, 2026)
- Integer Holdings Enters Agreement for Acquisition by KKR Valued at $5.7 Billion., $5.7B (August 4, 2026)
- Integer Holdings Corporation Enters Merger Agreement with Armstrong Parent, Inc. (August 2, 2026)
Who to call at Biosergen AB, and when
When Biosergen AB changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Biosergen AB raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Biosergen AB, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Biosergen AB. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Biosergen AB makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Flerie AB?
Flerie AB was acquired by Biosergen AB, based in Sweden. The deal was reported on September 15, 2026. Biosergen AB is a biotechnology company that develops innovative drug candidates for treating serious infections, particularly invasive fungal infections. Biosergen AB is privately held and operates in Biotechnology.
When did Biosergen AB acquire Flerie AB?
Biosergen AB's acquisition of Flerie AB was reported on September 15, 2026. Biosergen has applied for the delisting of its shares from the Nasdaq First North Growth Market. This move is conditional upon the completion of its merger with Flerie, indicating a strategic shift for both companies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Flerie AB do?
Flerie AB focuses on developing innovative treatments targeting various medical conditions. The company is engaged in advancing healthcare solutions through strategic mergers. It is privately held, operating in Biotechnology, and is based in Sweden.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.